Choline Bromide,
1927-06-6,
Choline, bromide,
UNII-CXC75P7WK9,
(2-hydroxyethyl)trimethylazanium bromide,
CXC75P7WK9,
(2-Hydroxyethyl)trimethylammonium bromide,
2-hydroxyethyl(trimethyl)azanium bromide,
NCGC00015219-03,
AC1L2MIV,
AC1Q1RJZ,
ACMC-1BVV7,
AC1O4X4J,
Choline-methyl-13C bromide,
DSSTox_CID_28938,
DSSTox_RID_83204,
DSSTox_GSID_49012,
SCHEMBL192988,
CHEMBL1256479,
DTXSID6049012,
CTK4E1061,
JJCWKVUUIFLXNZ-UHFFFAOYSA-M,
HMS3260D21,
EINECS 217-660-2,
Tox21_113514,
Tox21_500180,
ANW-13562,
MFCD00054244,
NSC293906,
AKOS015833071,
CCG-221484,
LP00180,
NSC-293906,
NCGC00093659-01,
NCGC00260865-01,
Trimethyl(2-hydroxyethyl)ammonium bromide,
CAS-1927-06-6,
TR-032210,
EU-0100180,
C 1754,
J-012465,
N-(2-hydroxyethyl)-N,N,N-trimethylammonium bromide,
SR-01000075745-1,
F8881-3843,
Ethanaminium, 2-hydroxy-N,N,N-trimethyl-, bromide (1:1),
Ethanaminium,2-hydroxy-N,N,N-trimethyl-, bromide (1:1),
CID74724,
AR-1I2187,
c0328,
Ethanaminium,N,N-trimethyl-, bromide,
SR-01000075745,